| 摘要 |
1. Technical Result Widening of assortment of the means for treating oestrone dependent tumors. 2. Essence New inhibitors representing sulphamate esters of formula (I) wherein R1 and R2 are each H, alkyl, alkenyl, cycloalkyl or aryl, or together represent an alkylene group optionally containing a heteroatom e.g. -O- or -NH-; and -O- polycycle represents the residue of a polycyclic alcohol such as a sterol, preferably sterol. Preferable compounds oestron-3-sulfamate, N,N-dimethyl oestron-3- sulfamate. 3. Field of Application Medicine.
|
